{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT00090129: Phase 3 Interventional Terminated Arthritis, Psoriatic
(2004)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01309425: Phase 1 Interventional Completed Healthy Volunteer
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00181623: Phase 2 Interventional Completed Lactation
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04129775: Phase 1/Phase 2 Interventional Completed Sensorineural Hearing Loss
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00994929: Phase 2 Interventional Completed Hemophilia A
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00017160: Phase 2 Interventional Withdrawn Stage III Adult Soft Tissue Sarcoma
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00281294: Phase 2 Interventional Terminated Arthritis, Rheumatoid
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00089154: Phase 2 Interventional Completed Noncontiguous Stage II Small Lymphocytic Lymphoma
(2004)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00322270: Phase 3 Interventional Completed Thrombosis
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04150900: Phase 2 Interventional Active, not recruiting Squamous Cell Carcinoma
(2020)
Source URL:
Class:
PROTEIN
